| 000 | 01713 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514161002.0 | ||
| 264 | 0 | _c20040706 | |
| 008 | 200407s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.47.11.3644-3646.2003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTremblay, Cécile L | |
| 245 | 0 | 0 |
_aFavorable interactions between enfuvirtide and 1-beta-D-2,6-diaminopurine dioxolane in vitro. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cNov 2003 |
||
| 300 |
_a3644-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 |
_aDioxolanes _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Viral |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aEnfuvirtide |
| 650 | 0 | 4 |
_aHIV Envelope Protein gp41 _xpharmacology |
| 650 | 0 | 4 |
_aHIV Infections _xvirology |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
| 650 | 0 | 4 |
_aPurine Nucleosides _xpharmacology |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xpharmacology |
| 700 | 1 | _aPoulin, Danielle L | |
| 700 | 1 | _aHicks, Jennifer L | |
| 700 | 1 | _aSelliah, Subajini | |
| 700 | 1 | _aChamberland, Annie | |
| 700 | 1 | _aGiguel, Françoise | |
| 700 | 1 | _aKollmann, Christopher S | |
| 700 | 1 | _aChou, Ting Chao | |
| 700 | 1 | _aDong, Huajin | |
| 700 | 1 | _aHirsch, Martin S | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 47 _gno. 11 _gp. 3644-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.47.11.3644-3646.2003 _zAvailable from publisher's website |
| 999 |
_c14318071 _d14318071 |
||